Clinical trial
Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial…
NCT02426944 · Charles University, Czech Republic, Other · Completed
Key facts
| NCT number | NCT02426944 |
|---|---|
| Title | Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation |
| Official title | Interventional Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in High-risk Patients With Atrial Fibrillation (PRAGUE-17 Study) |
| Acronym | PRAGUE-17 |
| Lead sponsor | Charles University, Czech Republic, Other |
| Collaborators | Ministry of Health, Czech Republic |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device, Drug |
| Interventions | NOAC, Left atrial appendage closure |
| Enrollment | 400 |
| Start date | Oct 13, 2015 |
| Primary completion | Jul 20, 2019 |
| Completion | Jul 20, 2019 |
| First posted | Apr 27, 2015 |
| Last update posted | Jun 11, 2021 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: